Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Cybis 10:25 THC:CBD oil for chronic back/neck pain in adults.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center [Phase 4]
Phase 4 clinical trial update on intraoperative sublingual sufentanil for acute pain in ambulatory surgery centers has completed with result…
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Virtual Reality Treatment for Adults With Chronic Back Pain [NA]
A completed clinical trial evaluating virtual reality treatment for adults with chronic back pain; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge [Phase 2, Phase 3]
A clinical trial comparing topical piroxicam with Soulagel for acute extremity pain after emergency department discharge has completed Phase…
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine submitted by Actavis Pharma, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for buprenorphine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P. to an existing approved product.
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride under an ANDA, indicating an additional approved formulation or use.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Lignocaine Only Versus Lignocaine Plus Magnesium Sulphate for Pain Relief After Episiotomy. [Phase 4]
Phase 4 trial comparing lignocaine alone vs lignocaine with magnesium sulfate for post-episiotomy pain relief.
-
FDA approval · 2022-06-13FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for buprenorphine hydrochloride from Advagen Pharma Ltd, enabling an additional generic version …
-
FDA approval · 2022-06-13FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P., indicating an update to the product's regulatory…
-
CLINICAL_TRIALS withdrawal · 2022-06-13Clinical Trial Update: Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain [Phase 4]
Phase 4 trial investigating intracameral phenylephrine/ketorolac for intraoperative pain has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection [Phase 4]
Phase 4 clinical trial evaluating erector spinae plane block catheters and intrathecal morphine for hepatic resection-related pain.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Developing a Pain Identification and Communication Toolkit [NA]
A terminated clinical trial investigating a pain identification and communication toolkit for dementia patients with chronic pain; results p…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS withdrawal · 2022-05-27Clinical Trial Update: ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL) [Phase 4]
A Phase 4 trial evaluating 0.75% bupivacaine for bilateral tubal ligation was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Dexamethasone in Pain Control After Total Knee Replacement [Phase 4]
Phase 4 trial evaluating dexamethasone for pain control after total knee replacement has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain [Phase 2, Phase 3]
Phase 2/3 trial evaluating intranasal oxytocin for chronic and pelvic pain has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses [NA]
A completed clinical trial comparing perineural local anesthetic continuous infusion versus automatic intermittent boluses for acute pain ma…
-
FDA approval · 2022-05-17FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Original Application (Alvogen Inc.)
FDA approved an original ANDA for buprenorphine transdermal system (generic buprenorphine) for chronic pain management.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Pilot of Pragmatic SBIRT Study [NA]
Pilot pragmatic SBIRT study completed; results posted in 2022 for substance use disorders and pain conditions.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy [Phase 4]
Phase 4 clinical trial evaluating intravenous dexamethasone for pain management with supraclavicular brachial plexus block in shoulder arthr…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: U/s Guided Oblique Subcostal Transversus Abdominis Plane Block Versus Erector Spinae Plane Block as Preemptive Analgesia [Phase 4]
Phase 4 trial comparing ultrasound-guided oblique subcostal TAP block versus erector spinae plane block for preemptive analgesia in surgical…
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride submitted by PAI Holdings/PAI Pharma, authorizing changes to the…
-
FDA approval · 2022-05-03FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for buprenorphine hydrochloride filed by Advagen Pharma Ltd, indicating an approval related to an ex…